V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20044308 | 20157389 | null | 42.9 | null | 2019-10-05 | 2020-02-11 | null | 02 | null | CAPECITABINE + CETUXIMAB + IRINOTECAN | 101585063 |
| 20044317 | 20157390 | 1.8 | null | null | 2016-11-12 | 2016-11-12 | null | 02 | null | CETUXIMAB + ENCORAFENIB | 100587040 |
| 20044345 | 20157392 | 1.6 | 66.9 | Palliative (P) | 2017-09-01 | 2017-09-01 | null | N | N | ABIRATERONE | 100031999 |
| 20044414 | 20157393 | 1.69 | 83 | Palliative (P) | 2017-12-31 | 2018-06-18 | null | 02 | N | LUTETIUM-177 | 100097485 |
| 20044489 | 20157394 | 1.73 | 81.7 | Curative (C) | 2016-11-18 | 2016-12-01 | null | N | Y | EVEROLIMUS | 100232387 |
| 20044921 | 20157397 | 1.57 | 65.3 | null | null | 2017-10-22 | null | 02 | null | LENALIDOMIDE | 101319700 |
| 20045057 | 20157400 | null | null | null | 2018-01-09 | 2018-07-04 | null | 01 | null | PEMBROLIZUMAB | 101089226 |
| 20045135 | 20157401 | 1.69 | 53.2 | Palliative (P) | 2016-10-31 | 2016-12-05 | null | 02 | N | TRIFLURIDINE + TIPIRACIL | 101003096 |
| 20045322 | 20157402 | 1.77 | 57.5 | Curative (C) | 2016-11-09 | 2016-11-09 | null | 02 | Y | TRIFLURIDINE + TIPIRACIL | 100086324 |
| 20045404 | 20157403 | null | 88.9 | 02 | null | 2019-08-04 | null | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100853686 |
| 20045591 | 20157405 | 1.66 | 73.6 | null | 2016-03-04 | 2016-03-11 | LUTETIUM-177 | 02 | null | CAPECITABINE + CISPLATIN + RT | 100856370 |
| 20045968 | 20157406 | 1.74 | 60.4 | Palliative (P) | 2016-10-10 | 2016-10-17 | null | 02 | N | NOT MATCHED | 101603231 |
| 20046270 | 20157407 | 0 | 72.8 | Neo-adjuvant (N) | 2017-10-25 | 2018-11-24 | null | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100604351 |
| 20046307 | 20157409 | 1.74 | 63.8 | Palliative (P) | 2019-04-09 | 2019-11-12 | Sunitinib | 02 | N | SUNITINIB | 101081096 |
| 20046308 | 20157410 | 0 | 83.3 | Curative (C) | null | 2017-12-13 | null | 02 | null | ABIRATERONE | 100848452 |
| 20046435 | 20157411 | null | 69 | Curative (C) | 2016-08-03 | 2017-07-13 | LUTETIUM-177 | N | Y | CETUXIMAB + ENCORAFENIB | 100584686 |
| 20046615 | 20157412 | 1.75 | 39.9 | Palliative (P) | 2019-01-04 | 2019-02-04 | EVEROLIMUS | 02 | N | EVEROLIMUS | 100101513 |
| 20047205 | 20157413 | 1.58 | 72.15 | null | 2017-08-31 | 2017-09-17 | null | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101704070 |
| 20047364 | 20157414 | 1.75 | 79.8 | Palliative (P) | 2019-08-08 | 2019-08-08 | null | 02 | N | OXALIPLATIN | 101479993 |
| 20047405 | 20157416 | 1.8 | 84.8 | null | 2017-09-09 | 2017-10-28 | null | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100560058 |
| 20047432 | 20157417 | 0 | 71.7 | Palliative (P) | 2019-04-25 | 2019-04-27 | null | 02 | N | PEMBROLIZUMAB | 101205070 |
| 20047460 | 20157418 | 1.68 | 75 | Adjuvant (A) | 2018-12-30 | 2018-12-31 | null | Y | N | PEMBROLIZUMAB | 101234913 |
| 20047893 | 20157420 | 1.72 | 71 | Adjuvant (A) | 2020-01-03 | 2020-01-12 | null | 02 | N | CAPECITABINE + CISPLATIN + RT | 100277209 |
| 20047927 | 20157421 | 1.8 | 77.1 | Curative (C) | 2019-09-01 | 2019-09-03 | null | 02 | N | SUNITINIB | 101012006 |
| 20047971 | 20157422 | 1.55 | 99.6 | null | 2014-04-10 | 2018-05-10 | LENALIDOMIDE | 02 | null | LENALIDOMIDE | 100754393 |
| 20048023 | 20157423 | 1.59 | null | null | 2018-09-17 | 2018-10-04 | null | N | N | CETUXIMAB + ENCORAFENIB | 100262178 |
| 20048114 | 20157424 | 1.72 | 58.8 | Curative (C) | 2017-10-13 | 2017-10-13 | null | 02 | Y | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 101694154 |
| 20048231 | 20157425 | 1.77 | 81.15 | Palliative (P) | 2016-09-01 | 2016-10-28 | null | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101616964 |
| 20048274 | 20157426 | 0 | 70 | Palliative (P) | null | 2020-08-27 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101868522 |
| 20048376 | 20157427 | 1.63 | 59 | null | 2016-12-26 | 2017-01-04 | null | null | null | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 100390085 |
| 20048404 | 20157428 | 1.73 | 64.4 | Curative (C) | null | 2019-10-18 | null | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 100202914 |
| 20048411 | 20157429 | 1.61 | 83.8 | null | 2019-09-13 | 2019-09-19 | LUTETIUM-177 | 02 | N | CISPLATIN + ETOPOSIDE | 101001089 |
| 20048486 | 20157431 | 1.61 | 59.1 | null | 2019-03-02 | 2019-03-03 | null | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101173998 |
| 20048719 | 20157432 | 1.71 | 80.8 | Curative (C) | 2018-02-21 | 2018-02-22 | null | 02 | N | MITOMYCIN INTRAVESICULAR | 101297643 |
| 20048731 | 20157433 | 1.8 | null | Neo-adjuvant (N) | 2019-11-26 | 2019-12-24 | null | 02 | Y | LUTETIUM-177 | 100235540 |
| 20048993 | 20157434 | 1.7 | 0 | Palliative (P) | null | null | null | 02 | N | ENZALUTAMIDE | 100973345 |
| 20049066 | 20157435 | 1.75 | 52.9 | 03 | 2019-12-24 | 2020-01-01 | null | 02 | N | SUNITINIB | 100666119 |
| 20049181 | 20157436 | 1.86 | 75.3 | null | null | 2018-09-10 | null | 2 | null | OXALIPLATIN | 101428312 |
| 20049282 | 20157437 | null | null | Neo-adjuvant (N) | 2016-12-01 | 2017-02-07 | null | 02 | N | SCALOP-2 TRIAL | 101109685 |
| 20049515 | 20157438 | 0 | null | null | 2019-10-27 | 2020-02-20 | ECF | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101543131 |
| 20049518 | 20157439 | 1.7 | 75.2 | null | 2019-06-13 | 2019-06-13 | null | 02 | null | PEMBROLIZUMAB | 100891746 |
| 20049527 | 20157440 | 1.75 | null | Palliative (P) | 2019-12-19 | 2019-12-20 | null | 2 | N | CISPLATIN | 100417218 |
| 20049586 | 20157441 | 1.7 | 64.1 | null | 2019-02-12 | 2019-02-12 | EVEROLIMUS | 02 | N | EVEROLIMUS | 100107531 |
| 20049623 | 20157443 | 1.84 | 0 | null | 2017-07-02 | 2017-10-14 | null | N | null | BEVACIZUMAB | 100270351 |
| 20049670 | 20157444 | 1.66 | 49.25 | null | 2016-06-26 | 2016-12-26 | null | 02 | null | SUNITINIB | 101170161 |
| 20049816 | 20157445 | 1.55 | 69 | Radical (R) | 2018-08-05 | 2018-08-05 | null | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100455706 |
| 20050043 | 20157447 | 1.65 | 39.4 | null | 2017-09-09 | 2018-01-03 | null | N | null | CISPLATIN | 100345266 |
| 20050100 | 20157448 | 1.72 | null | Neo-adjuvant (N) | 2019-01-26 | 2019-02-03 | null | 02 | N | SCALOP-2 TRIAL | 101852885 |
| 20050457 | 20157449 | 1.81 | 47.9 | Neo-adjuvant (N) | 2021-01-18 | 2021-01-18 | null | 02 | null | SCALOP-2 TRIAL | 100248698 |
| 20050458 | 20157450 | 1.54 | 61.8 | null | 2016-09-16 | 2018-10-14 | null | 2 | null | PEMBROLIZUMAB | 100410151 |